Katrisa Britton
Psychiatric/Mental Health · Amarillo, TXNPI 1639727381
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 1,080 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,080 payments — averaging $20.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$4K
- Neurocrine Biosciences, Inc.$4K
- Otsuka America Pharmaceutical, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- AbbVie$2K
- plus $7K from 19 others
What the payments were for
- Food & beverage$22,05299%
- Education$1581%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 214 | $4,467 |
| Neurocrine Biosciences, Inc. | 199 | $3,641 |
| Otsuka America Pharmaceutical, Inc. | 77 | $2,041 |
| Teva Pharmaceuticals USA, Inc. | 149 | $1,997 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 87 | $1,852 |
| AbbVie | 58 | $1,634 |
| Alkermes, Inc. | 72 | $1,596 |
| Axsome Therapeutics, Inc. | 70 | $1,355 |
| Lundbeck LLC | 58 | $1,201 |
| E.r. Squibb & Sons, L.L.C. | 16 | $462 |
| Acadia Pharmaceuticals Inc | 14 | $356 |
| Avanir Pharmaceuticals, Inc. | 8 | $333 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $310 |
| Vanda Pharmaceuticals Inc. | 10 | $173 |
| AstraZeneca | 1 | $125 |
| Ironshore Pharmaceuticals Inc. | 7 | $117 |
| Amgen | 1 | $113 |
| Janssen Scientific Affairs, LLC | 1 | $79 |
| Eisai Inc. | 4 | $78 |
| Corium, LLC | 3 | $75 |
| Tris Pharma Inc | 4 | $70 |
| Bayer | 1 | $50 |
| Indivior Inc. | 2 | $36 |
| Sunovion Pharmaceuticals Inc. | 3 | $34 |
| Alfasigma USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$813
- CAPLYTA$607
- ARISTADA$496
- REXULTI$492
- SPRAVATO$472
- LYBALVI$438
- VRAYLAR$437
- NUEDEXTA$250
- Austedo XR$250
- Auvelity$241
- BREZTRI$125
- ABILIFY MAINTENA$125
- ABILIFY ASIMTUFII$125
- COBENFY$125
- ARISTADA INITIO$124
- INVEGA SUSTENNA$119
- INVEGA TRINZA$119
- Prolia$113
How this compares
$22,210 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium | 32 | $657 |
| Quetiapine Fumarate | 43 | $451 |
| Risperidone | 39 | $445 |
| Gabapentin | 32 | $317 |
| Aripiprazole | 11 | $283 |
| Atorvastatin Calcium | 62 | $273 |
| Memantine Hcl | 18 | $265 |
| Buspirone Hcl | 31 | $263 |
| Duloxetine Hcl | 15 | $205 |
| Pantoprazole Sodium | 50 | $204 |
| Olanzapine | 13 | $177 |
| Bupropion XlBupropion Hcl | 16 | $166 |
| Donepezil Hcl | 18 | $151 |
| Sertraline Hcl | 24 | $145 |
| Trazodone Hcl | 40 | $140 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Amarillo
- Suzanne YawsAmarillo$25K
- Rae RobertsonAmarillo$13K
- Barbara NefsteadAmarillo$13K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.